3/15/2009
(c) William Schmidt, Ph.D.
---------------------------------------------------------------------------------------------------------------------
More to come, later Sunday night...
bullish.
BEAT Cardionet - Seems bound to re-test 36. Closing Power is at new high. Recent bulge of
CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States.
756 employees - Web Site: http://www.cardionet.com
Accumulation.
LEAP LEAP WIRELESS INTERN.
Leap Wireless International, Inc., together with its subsidiaries, provides digital wireless services under the
"Cricket" brand name in the United States. 3423 employees Web Site: http://www.leapwireless.com
STAR STARENT NETWORKS 16.92 -.44 Pulling back, preparatory to move past 19. Buy at 16.
STAR Leap Wireless 35.92 +.62 Pullback to 30 would make a good buy.
Starent Networks, Corp. provides infrastructure hardware and software products and services that
enable mobile operators to deliver multimedia services to their subscribers.
774 employees - Web Site: http://www.starentnetworks.com
HMSY HMS Holdings
HMS Holdings Corp., through its subsidiaries, provides cost containment
and payment accuracy services government-sponsored health and human
services programs in the United States
Web Site: http://www.hmsholdings.com
Watch
IMGN Immunogen Web Site: http://www.immunogen.com 220 employees
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the
United States. The company develops therapeutics for the treatment of cancer using its Tumor-Activated
Prodrug (TAP) technology, which uses antibodies to deliver a potent cytotoxic agent. Its products include
IMGN242, a Phase I clinical trial product for the treatment of CanAg-expressing gastric, pancreatic, and
colorectal cancer; and IMGN901, which is in three clinical trials for the treatment of multiple myeloma
as well as other hematological malignancies, small-cell lung cancer, ovarian cancer, and other cancers
of neuroendocrine origin. 210 employees
IMmunoGen, Inc. Announces Favorable IMGN901 Clinical Findings ...
American Society of
Hematology (ASH) 50th Annual Meeting and Exposition being held in San Francisco, CA.
"The study findings to date are highly encouraging
Short Sells
None - If the market were to weaken appreciably, O would think it will simply
re-tesgt its lows.
The best way to trade this would be with Stochastic S5 new sells.